Galectin Therapeutics
GALT
#8692
Rank
HK$1.39 B
Marketcap
HK$21.57
Share price
1.47%
Change (1 day)
113.02%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2025 (TTM): -HK$4.52

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$4.53. In 2024 the company made an earnings per share (EPS) of -HK$5.94 a decrease over its 2023 EPS that were of -HK$5.78.

EPS history for Galectin Therapeutics from 2001 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$4.52-23.9%
2024-HK$5.942.7%
2023-HK$5.7813.85%
2022-HK$5.0825%
2021-HK$4.0626.83%
2020-HK$3.205.13%
2019-HK$3.052.63%
2018-HK$2.97-22.45%
2017-HK$3.83-35.53%
2016-HK$5.94-13.64%
2015-HK$6.8812.82%
2014-HK$6.10-40%
2013-HK$10.1680.56%
2012-HK$5.63-32.08%
2011-HK$8.2813.98%
2010-HK$7.27-22.5%
2009-HK$9.38185.71%
2008-HK$3.28-70.83%
2007-HK$11.25118.18%
2006-HK$5.16-54.17%
2005-HK$11.25-14.29%
2004-HK$13.1347.37%
2003-HK$8.91-13.64%
2002-HK$10.32-24.14%
2001-HK$13.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-HK$95.50 2,006.90%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.78-117.24%๐Ÿ‡บ๐Ÿ‡ธ USA